In a setback to Novartis, the US Supreme Court has decided not to review a case in which the drugmaker argued that punitive damages should not be awarded by juries in product liability lawsuits. Why? Novartis hoped to convince the court that such penalties purportedly encroach on the ability of the FDA to enforce its authority.
Help employers find you! Check out all the jobs and post your resume.
